Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$119.39 USD

119.39
6,741,790

+1.50 (1.27%)

Updated Oct 18, 2024 04:00 PM ET

After-Market: $119.40 +0.01 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth A Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 29% (72 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

The Zacks Analyst Blog Highlights: Abbott Lab, QIAGEN, Quidel, Hologic and Quest Diagnostics

Urmimala Biswas headshot

Testing Space in Focus Again Thanks to New Wave of Coronavirus

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

Abbott (ABT) to Expand in Booming TBI Space on New Approval

If positive, Abbott's (ABT) TBI blood test result complements CT scans to help evaluate whether a suspected patient has a TBI.

Abbott (ABT) Gains But Lags Market: What You Should Know

Abbott (ABT) closed the most recent trading day at $111.30, moving +0.97% from the previous trading session.

Why Abbott (ABT) is Poised to Beat Earnings Estimates Again

Abbott (ABT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Abbott (ABT) Outpaces Stock Market Gains: What You Should Know

Abbott (ABT) closed at $109.49 in the latest trading session, marking a +0.97% move from the prior day.

Urmimala Biswas headshot

5 Soaring MedTech Stocks to Buy for More Growth in 2021

We have selected five MedTech growth stocks with further rooms for improvement in 2021.

Trina Mukherjee headshot

3 Soaring MedTech Stocks That Might Lose Ground in 2021

Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Abbott (ABT) closed at $108.09, marking a -0.81% move from the previous day.

4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021

Four large-cap MedTech stocks are currently flourishing on the back of several positive developments

Abbott (ABT) Broadens Pediatric Client Base With New Labeling

Abbott's (ABT) HeartMate 3 LVAD or heart pump is an implantable device that pumps blood through the body in people whose hearts are too weak to do so naturally.

Debanjana Dey headshot

5 MedTech Stocks That Have Outperformed the Industry in 2020

Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

Abbott (ABT) Gains CE Mark for Quantitative Serology Testing

The test is set to be used on Abbott's (ABT) ARCHITECT and Alinity i platforms.

Abbott (ABT) Stock Moves -0.23%: What You Should Know

Abbott (ABT) closed at $106.79 in the latest trading session, marking a -0.23% move from the prior day.

Here's Why You Should Hold on to Tandem Diabetes (TNDM) Stock

Investors continue to be optimistic about Tandem Diabetes (TNDM) on robust pump sales and shipments.

Abbott (ABT) Launches Immunity Boosting Hydration Solution

Abbott's (ABT) latest hydration solution with specifically chosen nutrients along with optimal balance of electrolytes and glucose is expected to boost immunity.

Sriparna Ghosal headshot

3 Beaten-Down MedTech Stocks Set to Stage a Comeback in 2021

Three currently-undervalued MedTech stocks are flourishing on the back of a few uptrends.

Abbott (ABT) Stock Moves -0.45%: What You Should Know

Abbott (ABT) closed the most recent trading day at $106.32, moving -0.45% from the previous trading session.

Trina Mukherjee headshot

4 Top-Ranked MedTech Stocks to Bet on Heading Into 2021

Grab these four top stocks that have shown tremendous promise despite market volatility due to the pandemic and have the potential to continue their bull run in 2021.

Abbott's (ABT) Libre 2 Cleared in Canada, Boosts CGM Prospects

Abbott's (ABT) next-generation FreeStyle Libre 2 system aims to provide a better quality of life to diabetics in Canada at the same affordable price of the current FreeStyle Libre system.

Abbott (ABT) Dips More Than Broader Markets: What You Should Know

In the latest trading session, Abbott (ABT) closed at $107.53, marking a -0.57% move from the previous day.

Debanjana Dey headshot

4 MedTech Stocks Gaining Ground on COVID-19 Test Kit Success

Here are a few coronavirus-testing MedTech stocks that investors can scoop up to reap profits amid the pandemic-battered stock market situation.

Pediatric Medical Space Thrives Amid COVID-19: 3 Stocks in Focus

Among several domains within the MedTech space, several pediatric medical device stocks have been gaining traction amid the coronavirus pandemic

The Zacks Analyst Blog Highlights: NVIDIA, Pfizer, Abbott, UPS and ICICI

The Zacks Analyst Blog Highlights: NVIDIA, Pfizer, Abbott, UPS and ICICI

Sheraz Mian headshot

Top Stock Reports for NVIDIA, Pfizer & Abbott

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA (NVDA), Pfizer (PFE) and Abbott Laboratories (ABT).